Current evidence supports individualized use of MOUD while accounting for comorbidities, polypharmacy, and age-related physiologic changes, and future research should prioritize geriatric-specific screening tools, diagnostic frameworks, treatment protocols, and clinical outcomes.
Jade Hannan, L. Mccracken, Jorge A. Romero-Ortiz et al.· Current Addiction Report· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.